Identifier |
20220213_nanos_posters_227 |
Title |
Effect of Inebilizumab on Attack Severity and Biomarkers of Disease Activity in NMOSD |
Creator |
Jeffrey Bennett; Michael Smith; Brian Weinshenker |
Affiliation |
(JB) University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado; (MS) Horizon Therapeutics plc, Deerfield, Illinois; (BW) Mayo Clinic, Rochester, Illinois |
Subject |
Neuro-ophthalmology & Systemic Disease (eg. MS, MG, Thyroid) |
Description |
NMOSD typically presents with optic neuritis (ON) and myelitis. Inebilizumab reduces risk of attack and disability. We examined (1) the relationship of attack severity with serum glial fibrillary acidic protein (sGFAP) and serum neurofilament (sNfL) with a focus on ON attacks and (2) the effect of inebilizumab on attack severity and serum biomarkers. |
Date |
2022-02 |
Language |
eng |
Format |
application/pdf |
Type |
Text |
Source |
2022 North American Neuro-Ophthalmology Society Annual Meeting |
Relation is Part of |
NANOS Annual Meeting 2022: Poster Session I: Neuro-Ophthalmic Disorders of Neurologic and Systemic Diseases |
Collection |
Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu |
Publisher |
Spencer S. Eccles Health Sciences Library, University of Utah |
Holding Institution |
North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416 |
Rights Management |
Copyright 2022. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
ARK |
ark:/87278/s6d629qg |
Context URL |
The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/ |
Setname |
ehsl_novel_nam |
ID |
2065045 |
Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6d629qg |